Cargando…

Collagenase injections for Dupuytren's disease: prospective cohort study assessing 2-year treatment effect durability

OBJECTIVES: To assess 2-year durability of joint contracture correction following collagenase injections for Dupuytren's disease. DESIGN: Prospective cohort study. SETTING: Orthopaedic Department in Sweden. PARTICIPANTS: Patients with palpable Dupuytren's cord and active extension deficit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lauritzson, Anna, Atroshi, Isam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Surgery
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353323/ https://www.ncbi.nlm.nih.gov/pubmed/28298365 http://dx.doi.org/10.1136/bmjopen-2016-012943

Ejemplares similares

Surgical fasciectomy versus collagenase injection in treating recurrent Dupuytren disease: study protocol of a randomised controlled trial
por: Nordenskjöld, Jesper, et al.
Publicado: (2019)

Collagenase injections for Dupuytren disease: 3-year treatment outcomes and predictors of recurrence in 89 hands
por: Nordenskjöld, Jesper, et al.
Publicado: (2019)

Risk Factors for Long-Term Contracture Recurrence after Collagenase Injection for Dupuytren Disease: A Prospective Cohort Study
por: Eckerdal, David, et al.
Publicado: (2023)

Costs for collagenase injections compared with fasciectomy in the treatment of Dupuytren's contracture: a retrospective cohort study
por: Atroshi, Isam, et al.
Publicado: (2014)

Collagenase treatment of Dupuytren’s contracture using a modified injection method: A prospective cohort study of skin tears in 164 hands, including short-term outcome
por: Atroshi, Isam, et al.
Publicado: (2015)

Delayed vascular complication after collagenase injection for Dupuytren disease
por: Nordenskjöld, Jesper, et al.
Publicado: (2023)

Responsiveness of the patient-specific Canadian occupational performance measure and a fixed-items activity limitations measure in patients with dupuytren disease
por: Lauritzson, Anna, et al.
Publicado: (2023)

Cost-Effectiveness and Patient Outcomes of Injectable Collagenase to Treat Dupuytren’s Contracture
por: Sahemey, Rajpreet S, et al.
Publicado: (2021)

Return-to-Function Following Treatment of Dupuytren Contracture With Collagenase Clostridium Histolyticum Versus Fasciectomy
por: Divino, Victoria M., et al.
Publicado: (2020)

Collagenase Clostridium Histolyticum Injection for Dupuytren Contracture: 2-Year Follow-up
por: Nayar, Suresh K., et al.
Publicado: (2019)

Clostridium Histolyticum Collagenase Underdosed for Multicord Injection in Dupuytren’s Disease: A Retrospective Cohort Study
por: Boriani, Filippo, et al.
Publicado: (2022)

Dupuytren Disease: A Retrospective Cohort Study Comparing Collagenase Injection and Percutaneous Needle Fasciotomy
por: Mehdiyev, Turkhan, et al.
Publicado: (2022)

Needle Fasciotomy or Collagenase Injection in the Treatment of Dupuytren’s Contracture: A Retrospective Study
por: Abdelrahman, Islam, et al.
Publicado: (2020)

Botulinum toxin as an adjunct for severe Dupuytren’s contracture treated with collagenase injections
por: Denkler, Keith A., et al.
Publicado: (2022)

The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease
por: Thomas, Alexis, et al.
Publicado: (2010)

Collagenase Management of Multicord Dupuytren’s Disease under Intravenous Sedation: A Prospective Cohort Study
por: Wiseman, Jeremy, et al.
Publicado: (2019)

Examiners’ influence on the measured active and passive extension deficit in finger joints affected by Dupuytren disease
por: Nordenskjöld, Jesper, et al.
Publicado: (2018)

Multiple concurrent collagenase clostridium histolyticum injections to dupuytren’s cords: an exploratory study
por: Coleman, Stephen, et al.
Publicado: (2012)

Prospective observation of Clostridium histolyticum collagenase for the treatment of Dupuytren’s disease in 788 patients: the Austrian register
por: Rohit, Arora, et al.
Publicado: (2019)

A new finger-preserving procedure as an alternative to amputation in recurrent severe Dupuytren contracture of the small finger
por: Eiriksdottir, Asa, et al.
Publicado: (2019)

D3. Time from Collagenase Injection to Manipulation Does Not Affect Outcomes in Dupuytren’s Disease
por: Bingham, Elijah G., et al.
Publicado: (2023)

DupuytrEn Treatment EffeCtiveness Trial (DETECT): a protocol for prospective, randomised, controlled, outcome assessor-blinded, three-armed parallel 1:1:1, multicentre trial comparing the effectiveness and cost of collagenase clostridium histolyticum, percutaneous needle fasciotomy and limited fasciectomy as short-term and long-term treatment strategies in Dupuytren’s contracture
por: Räisänen, Mikko P., et al.
Publicado: (2018)

Comparative Effectiveness of Needle Aponeurotomy and Collagenase Injection for Dupuytren’s Contracture: A Multicenter Study
por: Zhou, Chao, et al.
Publicado: (2017)

Vascular Complication after Collagenase Injection and Manipulation for Dupuytren’s Contracture: A Case Report
por: Kawano, Yusuke, et al.
Publicado: (2019)

Acute Pain Intensity After Collagenase Clostridium histolyticum Injection in Patients With Dupuytren Contracture
por: Noto, Kimitoshi, et al.
Publicado: (2019)

Long-Term Outcomes of Collagenase Clostridium Histolyticum Injection for Palmar Dupuytren’s Deformity Correction
por: Kasture, Sarang, et al.
Publicado: (2021)

CLINICAL RESULTS OF COLLAGENASE TREATMENT FOR DUPUYTREN’S DISEASE: A CASE SERIES STUDY WITH 2-YEARS FOLLOW-UP
por: Basso, Morena Anna, et al.
Publicado: (2023)

Collagenase Clostridium histolyticum Injection Therapy Improves Health-related Quality of Life in Patients with Dupuytren’s Disease
por: Kuboi, Takuro, et al.
Publicado: (2021)

Late Complications of Clinical Clostridium Histolyticum Collagenase Use in Dupuytren's Disease
por: Rozen, Warren M., et al.
Publicado: (2012)

Phalangeal Fracture During Attempted Dupuytrens Release Following Clostridial Collagenase Injection: Case Report
por: Lewallen, Laura W, et al.
Publicado: (2017)

Safety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren’s contracture
por: Peimer, C. A., et al.
Publicado: (2015)

Retraction: Late Complications of Clinical Clostridium Histolyticum Collagenase Use in Dupuytren's Disease
por: Rozen, Warren M., et al.
Publicado: (2012)

111. A Long-term Comparison of Collagenase versus Fasciectomy in the Treatment of Dupuytren’s Contracture
por: Steppe, Cyrus S., et al.
Publicado: (2023)

Does Use of a Night Extension Orthosis Improve Outcomes in Patients With Dupuytren Contracture Treated With Injectable Collagenase?
por: Bowers, Nathan Lorris, et al.
Publicado: (2021)

Incidence of Tendon Rupture After Collagenase Clostridium Histolyticum Injection for Treatment of Dupuytren Contracture in Adults: A Postmarketing Safety Analysis
por: Peimer, Clayton A., et al.
Publicado: (2022)

Collagenase Dupuytren Contracture: Achieving Single Treatment Success with a Hand Therapist-Based Protocol
por: Malafa, Menyoli M., et al.
Publicado: (2016)

Hand therapy or not following collagenase treatment for Dupuytren’s contracture? Protocol for a randomised controlled trial
por: Aglen, Terese, et al.
Publicado: (2019)

The CeCORD-J study on collagenase injection versus aponeurectomy for Dupuytren's contracture compared by hand function and cost effectiveness
por: Yamamoto, Michiro, et al.
Publicado: (2022)

Efficacy and safety of collagenase clostridium histolyticum for Dupuytren disease nodules: a randomized controlled trial
por: Costas, Bronier, et al.
Publicado: (2017)

Treatment of Dupuytren Disease With Injectable Collagenase in a Veteran Population: A Case Series at the Department of Veterans Affairs New Jersey Health Care System
por: Sood, Aditya, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_atgqrifukankipvicrk9n0ta9o